13F-HR filed by Avidity Partners Management LP
Avidity Partners Management LP filed this 13F-HR for the quarter ended 2020-06-30, filed 2020-08-14, with 57 holding rows worth $1,560,198,000.
- Accession
- 0001791827-20-000004
- Filer
- CIK 1791827
- Filed
- 2020-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2020
A holdings report, 57 entries on the cover page, a total value of $1,560,198,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,560,198,000 with VALUE read as thousands by filing date, 13F file number 028-20028. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| AbbVie,Inc. | 00287Y109 | COM | 1,545,400 | $151,727,000 | thousands by filing date | |
| REGENERON PHARMACEUTICALS COM | 75886F107 | Stock | 132,100 | $82,384,000 | thousands by filing date | |
| BIOHAVEN PHARMACEUTICAL HOLDIN | G11196105 | COM | 1,104,500 | $80,750,000 | thousands by filing date | |
| BAXTER INTL INC | 071813109 | COM | 800,900 | $68,957,000 | thousands by filing date | |
| IMMUNOMEDICS INC | 452907108 | COM | 1,911,300 | $67,736,000 | thousands by filing date | |
| EXELIXIS INC COM | 30161Q104 | Stock | 2,694,070 | $63,957,000 | thousands by filing date | |
| ALEXION PHARMACEUTICALS INC | 015351109 | COM | 507,700 | $56,984,000 | thousands by filing date | |
| HOLOGIC INC | 436440101 | COM | 817,200 | $46,580,000 | thousands by filing date | |
| SEATTLE GENETICS INC | 812578102 | COM | 250,900 | $42,633,000 | thousands by filing date | |
| AURINIA PHARMACEUTICALS INC COM | 05156V102 | Stock | 2,474,599 | $40,212,000 | thousands by filing date | |
| MOMENTA PHARMACEUTICALS INC | 60877T100 | COM | 1,150,000 | $38,261,000 | thousands by filing date | |
| CHEMOCENTRYX INC | 16383L106 | COM | 645,800 | $37,159,000 | thousands by filing date | |
| ARVINAS INC | 04335A105 | COM | 1,076,900 | $36,119,000 | thousands by filing date | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 404,900 | $33,315,000 | thousands by filing date | |
| KADMON HLDGS INC | 48283N106 | COM | 6,426,700 | $32,905,000 | thousands by filing date | |
| PRINCIPIA BIOPHARMA INC | 74257L108 | COM | 548,500 | $32,795,000 | thousands by filing date | |
| ZENTALIS PHARMACEUTICALS INC | 98943L107 | COMMON STOCK | 674,487 | $32,389,000 | thousands by filing date | |
| HORIZON THERAPEUTICS PLC | G46188101 | SHS | 536,200 | $29,802,000 | thousands by filing date | |
| ESPERION THERAPEUTICS INC NEW COM | 29664W105 | Stock | 559,700 | $28,718,000 | thousands by filing date | |
| AVANTOR INC COM | 05352A100 | Stock | 1,612,000 | $27,404,000 | thousands by filing date | |
| VIR BIOTECHNOLOGY INC | 92764N102 | COM | 620,600 | $25,426,000 | thousands by filing date | |
| Mersana Therapeutics Inc | 59045L106 | Common Stock | 1,069,600 | $25,029,000 | thousands by filing date | |
| DYNAVAX TECHNOLOGIES CORP | 268158201 | COM NEW | 2,674,154 | $23,720,000 | thousands by filing date | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 1,527,400 | $22,636,000 | thousands by filing date | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 185,100 | $22,582,000 | thousands by filing date | |
| SYNEOS HEALTH INC | 87166B102 | CL A | 366,500 | $21,349,000 | thousands by filing date | |
| BRISTOL-MYERS SQUIBB CO | 110122157 | RIGHT 99/99/9999 | 5,786,941 | $20,717,000 | thousands by filing date | |
| BIOXCEL THERAPEUTICS INC | 09075P105 | COM | 388,095 | $20,573,000 | thousands by filing date | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 738,547 | $20,273,000 | thousands by filing date | |
| CRISPR THERAPEUTICS AG NAMEN AKT | H17182108 | Stock | 274,300 | $20,158,000 | thousands by filing date | |
| HARPOON THERAPEUTICS INC | 41358P106 | COM | 1,206,351 | $20,025,000 | thousands by filing date | |
| MCKESSON CORP COM | 58155Q103 | Stock | 128,000 | $19,638,000 | thousands by filing date | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 1,331,100 | $18,915,000 | thousands by filing date | |
| COHERUS ONCOLOGY INC | 19249H103 | COM | 1,023,500 | $18,280,000 | thousands by filing date | |
| EDITAS MEDICINE INC | 28106W103 | COM | 600,000 | $17,748,000 | thousands by filing date | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 118,900 | $17,585,000 | thousands by filing date | |
| ASTRAZENECA PLC SPONSORED ADR | 046353108 | ADR | 325,990 | $17,242,000 | thousands by filing date | |
| ALECTOR INC | 014442107 | COMMON STOCK | 686,400 | $16,776,000 | thousands by filing date | |
| Medtronic Plc | G5960L103 | COM | 173,700 | $15,928,000 | thousands by filing date | |
| PREVAIL THERAPEUTICS INC | 74140Y101 | COM | 1,028,800 | $15,329,000 | thousands by filing date | |
| ARCUS BIOSCIENCES INC | 03969F109 | COM | 589,000 | $14,572,000 | thousands by filing date | |
| ADAPTIMMUNE THERAPEUTICS PLC | 00653A107 | SPONDS ADR | 1,438,000 | $14,394,000 | thousands by filing date | |
| ANIKA THERAPEUTICS INC | 035255108 | COM | 362,490 | $13,677,000 | thousands by filing date | |
| ROYALTY PHARMA PLC | G7709Q104 | SHS CLASS A | 200,000 | $9,710,000 | thousands by filing date | |
| SURFACE ONCOLOGY INC | 86877M209 | COM | 1,478,699 | $9,700,000 | thousands by filing date | |
| DECIPHERA PHARMACEUTICALS IN | 24344T101 | COM | 156,266 | $9,332,000 | thousands by filing date | |
| INTELLIA THERAPEUTICS INC | 45826J105 | COM | 418,178 | $8,790,000 | thousands by filing date | |
| VERASTEM INC | 92337C104 | COM | 4,414,991 | $7,594,000 | thousands by filing date | |
| 1LIFE HEALTHCARE INC | 68269G107 | COM | 200,000 | $7,264,000 | thousands by filing date | |
| AKOUOS INC | 00973J101 | COM | 315,000 | $7,088,000 | thousands by filing date | |
| AVIDITY BIOSCIENCES INC COM | 05370A108 | Stock | 234,814 | $6,636,000 | thousands by filing date | |
| RETROPHIN INC | 761299106 | COM | 250,000 | $5,103,000 | thousands by filing date | |
| LEGEND BIOTECH CORP | 52490G102 | SPONSORED ADS | 100,000 | $4,256,000 | thousands by filing date | |
| AVADEL PHARMACEUTICALS, PLC | 05337M104 | COMMON STOCK-FO | 457,951 | $3,700,000 | thousands by filing date | |
| FUSION PHARMACEUTICALS INC | 36118A100 | COM | 164,554 | $2,875,000 | thousands by filing date | |
| ZOGENIX INC. | 98978L204 | Common Stock | 97,870 | $2,643,000 | thousands by filing date | |
| BIORA THERAPEUTICS INC | 74319F107 | COM | 238,680 | $2,148,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001791827-20-000004 | this filing | 2020-08-14 | acceptance time not in the bulk data set |